A two-dose schedule could make HIV vaccines more effective
网页2 天之前 · Each year, HIV infects more than 1 million people around the world, and some of those people do not have access to antiviral drugs. An effective vaccine could prevent many of those infections. One promising vaccine now in clinical trials consists of an HIV protein called an envelope trimer, along with a nanoparticle called SMNP.
Researchers determine a two-dose schedule could make HIV …
网页2 天之前 · Each year, HIV infects more than 1 million people around the world, and some of those people do not have access to antiviral drugs. An effective vaccine could prevent many of those infections.
Engineered Virus Steals Proteins From H.I.V., Pointing to New …
网页2024年8月8日 · Scientists have developed a new weapon against H.I.V.: a molecular mimic that invades a cell and steals essential proteins from the virus. A study published in Science on Thursday reported...
At #UNGA79 UNAIDS will call on global leaders to roll-out new ...
网页3 天之前 · The Executive Director of UNAIDS, Winnie Byanyima, is leading the UNAIDS delegation at The Summit of the Future and the 79th United Nations General Assembly in New York to urge world leaders to make new HIV prevention technologies available to people at risk of HIV infection and revitalize multilateralism in responding to global crises.
HIV: how close are we to a vaccine — or a cure? - Nature
网页2024年9月2日 · Longer-term solutions are in the works. But how close are we to a cure for HIV — or a vaccine? Nature spoke with specialists to find out. What advances have been made in the treatment of HIV?
Twice-yearly shot proves successful at preventing HIV infection …
网页2024年7月24日 · Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa.
New HIV drug can only offer hope of ending AIDS if all have …
网页2024年7月10日 · New HIV drug can only offer hope of ending AIDS if all have access, UNAIDS says. GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for …
After decades of failures, researchers have renewed hopes for an ...
网页2024年3月6日 · Despite 20 years of failures in major HIV vaccine trials, researchers say recent advances have likely, hopefully, put them on the right track to develop a highly effective vaccine.
Long-Acting Drugs May Revolutionize H.I.V. Prevention and …
网页2024年4月17日 · The drug is in multiple late-stage trials as a long-acting H.I.V. preventative in various groups, including cisgender women. Lenacapavir is also being tested as a treatment in the form of a...
FDA Approves New HIV Drug for Adults with Limited Treatment …
网页2023年1月4日 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
跳至内容